Matches in UGent Biblio for { <https://biblio.ugent.be/publication/1232812#aggregation> ?p ?o. }
Showing items 1 to 58 of
58
with 100 items per page.
- aggregation classification "A1".
- aggregation creator B291081.
- aggregation creator B291082.
- aggregation creator B291083.
- aggregation creator B291084.
- aggregation creator B291085.
- aggregation creator B291086.
- aggregation creator B291087.
- aggregation creator B291088.
- aggregation creator B291089.
- aggregation creator B291090.
- aggregation creator B291091.
- aggregation creator B291092.
- aggregation creator B291093.
- aggregation creator B291094.
- aggregation creator B291095.
- aggregation creator B291096.
- aggregation creator B291097.
- aggregation creator B291098.
- aggregation creator B291099.
- aggregation creator B291100.
- aggregation creator B291101.
- aggregation creator B291102.
- aggregation creator B291103.
- aggregation creator B291104.
- aggregation creator B291105.
- aggregation creator B291106.
- aggregation creator person.
- aggregation date "2011".
- aggregation format "application/pdf".
- aggregation hasFormat 1232812.bibtex.
- aggregation hasFormat 1232812.csv.
- aggregation hasFormat 1232812.dc.
- aggregation hasFormat 1232812.didl.
- aggregation hasFormat 1232812.doc.
- aggregation hasFormat 1232812.json.
- aggregation hasFormat 1232812.mets.
- aggregation hasFormat 1232812.mods.
- aggregation hasFormat 1232812.rdf.
- aggregation hasFormat 1232812.ris.
- aggregation hasFormat 1232812.txt.
- aggregation hasFormat 1232812.xls.
- aggregation hasFormat 1232812.yaml.
- aggregation isPartOf urn:issn:0105-4538.
- aggregation language "eng".
- aggregation rights "I have transferred the copyright for this publication to the publisher".
- aggregation subject "Medicine and Health Sciences".
- aggregation title "How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA2LEN statement".
- aggregation abstract "P>Specific immunotherapy (SIT) is one of the treatments for allergic rhinitis. However, for allergists, nonspecialists, regulators, payers, and patients, there remain gaps in understanding the evaluation of randomized controlled trials (RCTs). Although treating the same diseases, RCTs in SIT and pharmacotherapy should be considered separately for several reasons, as developed in this study. These include the severity and persistence of allergic rhinitis in the patients enrolled in the study, the problem of the placebo, allergen exposure (in particular pollen and mite), the analysis and reporting of the study, the level of symptoms of placebo-treated patients, the clinical relevance of the efficacy of SIT, the need for a validated combined symptom-medication score, the differences between children and adults and pharmacoeconomic analyses. This statement reviews issues raised by the interpretation of RCTs in sublingual immunotherapy. It is not possible to directly extrapolate the rules or parameters used in medication RCTs to SIT. It also provides some suggestions for the research that will be needed. Interestingly, some of the research questions can be approached with the available data obtained from large RCTs.".
- aggregation authorList BK574934.
- aggregation endPage "774".
- aggregation issue "6".
- aggregation startPage "765".
- aggregation volume "66".
- aggregation aggregates 1904820.
- aggregation isDescribedBy 1232812.
- aggregation similarTo j.1398-9995.2011.02590.x.
- aggregation similarTo LU-1232812.